Health Canada warning on Idelalisib (Zydelig) ... - CLL Support
Health Canada warning on Idelalisib (Zydelig) Increased Risk of Fatal and Serious Infections
You need to be a member of this community to see this post.
Read more about...
9 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Minimizing the risk of infections
I'm recently diagnosed with CLL and have two children (ages 10 and 11) and one young adult (22)...
Treatment-naive or relapsed CLL patients will soon have zanubrutinib/Brukinsa as a treatment option in the EU
The EC approval is based on positive results from two Phase 3 clinical trials: SEQUOIA...
Please share experience of venetoclax plus obinutuzimab or acalabrutinib mono treatment in an important survey
Reminder - please complete the survey if you are any of the above treatments. At the moment we...
With CLL, infections can be fatal. Why hasn't rapid sequencing for serious infections and sepsis (Metagenomics) become standard of care?
In 2014, Sharon Peacock, a professor of microbiology at the Unviersity of Cambridge, wrote an...
Curious to know the preferred first-line treatment for CLL in other countries
I live in the US, and my understanding is that Ibrutinib is increasingly the preferred first-line...
Related Posts
- Use of MRD Status Following Obinutuzumab/Ibrutinib to Guide Subsequent Intensification of Therapy in CLL
Survey for CLL patients having taken Venetoclax or Acalabrutinib
zydelig
CLL INFORMATION - A developing reliable and current international list of CLL Information & Resources.
Interesting article on treatment choices
